Skip to content

M. He

2 papers in the library · publishing 2009-2011

Papers

Sort Most recent Most cited

A phase 0 microdosing trial to identify chemoresistance in bladder cancer.

Journal of Clinical Oncology March 1, 2011 C. Pan, S. Wang, M. He et al.

264 Background: DNA damage is the critical step in cancer cell response to platinum (Pt) chemotherapy. We hypothesize that low levels of Pt-induced DNA damage are predictive of chemoresistance. Accelerator mass spectrometry (AMS) is an ultrasensitive method for measuring radiocarbon. By measuring 14C bound to DNA, AMS can detect carboplatin-induced DNA damage after patients receive one subtoxic...

Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes

Journal of Clinical Oncology May 20, 2009 C. Pan, T. Li, M. He et al.

2543 Background: DNA damage is the critical step in cancer cell response to platinum (Pt) chemotherapy. We hypothesize that low levels of Pt-induced DNA damage are predictive of chemoresistance. Accelerator mass spectrometry (AMS), an ultrasensitive method for measuring radiocarbon, can detect [14C]carboplatin bound to the DNA of cancer cells from cell culture, mice bearing tumor xenografts and...